Amyris

Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to the health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Earnings data Q1 2024

The principal business of Tara Gold Resources Corp. is the acquisition, exploration and development of high-quality precious metals projects with potential for economic commercial value. Tara Gold is currently focused on acquiring and developing properties in the natural resource belt of the Sierra Madre Occidental and other prolific areas in the states of Chihuahua, Sonora, and Sinaloa, Mexico.  Tara Gold provides investors growth exposure with a diversified exploration portfolio, multiple multi-million ounce targets and several near term production scenarios. Tara Gold owns equity positions in Cayden Resources Inc. (TSX-V: CYD) and Tara Minerals Corp. (TARM.OB), a public US company which explores and develops high-quality precious & non-precious metals and mineral projects in Mexico.

Avalara Inc

Axon Enterprise

BlackRock Health Sciences Trust II

BlackRock Science and Technology Trust II

Entegris

Fox Factory Hld

Freshpet

Masimo

Phreesia Inc

Invesco QQQ

Bio-Techne

Vroom

BIGZ launched late in March, they have finally updated their holdings to include the top ten.

BIGZ: Holdings Updated - Great Diversifier Into Growth Names

Carvana

Fluor

Hexcel

Marathon Digital Holdings

Although stocks were deeply in the red in overnight trading, the jobless claims can be credited for the sharp reversal today. Q.ai's artificial intelligence systems assessed each firm to find the best short plays.

Amyris Inc And Carvana Co Among Today's Top Shorts

Kirby

Blink Charging

Livent Corp

Plug Power

The major indices have all traded in the red. But, if you're looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Shorts.

Artificial Intelligence Identifies Amyris And Kirby Corp As Top Shorts As Growth Stocks Drop

EMERYVILLE, Calif., May 18, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has obtained commitments for over 10,000 new doors at retail stores such as Sephora North America, CVS, KeHe North America, Loblaws Super Saver, Rite Aid, Walgreens, Walmart Canada and Wegmans to sell Amyris clean beauty consumer products.

Amyris Clean Beauty Consumer Brands Expand By Over 10,000 North American Retail Doors

Redfin

Reata Pharmaceuticals

Going into today, the Dow Jones continued its sell-off and fell more than 150 points while the S&P 500 lost 0.6% and the Nasdaq﻿﻿ dipped more than 1%. Our AI has identified the following stocks rated Top Short today.

AI Model Rates Redfin And Carvana Top Short Today

EMERYVILLE, Calif., May 11, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that management will participate in a fireside chat at the virtual Morgan Stanley Global Consumer Ingredients Day on Tuesday, May 18 th at 10:45 am ET.

Amyris to Present at the Virtual Morgan Stanley Global Consumer Ingredients Day on May 18, 2021

Amyris, Inc. (AMRS) CEO John Melo on Q1 2021 Results - Earnings Call Transcript

CEVA

Maxar Technologies

The major indices are trading mixed amid signs that reopening and recovery are on the horizon. If you're looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Shorts.

Redfin Among Today's Best Short Plays As The Dow Trades Around Record High And The Nasdaq Continues Losing Streak

EMERYVILLE, Calif., May 6, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced financial results for its first quarter ended March 31, 2021.

Amyris, Inc. Reports First Quarter 2021 Financial Results

EMERYVILLE, Calif., May 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that Pipette™, its clean baby and mothers skincare brand, will partner with non-profit organization, Baby2Baby to donate 200,000 units of its award-winning hand sanitizer to families living in poverty nationwide.

Amyris Brand Pipette™ Partners With Baby2baby To Help Babies And Families In Need

Amyris' (AMRS) Q1 results are likely to have benefited from continued strong growth in its consumer brands.

Amyris (AMRS) to Report Q1 Earnings: What's in the Offing?

Ingredion

EMERYVILLE, Calif. and WESTCHESTER, Ill.

Amyris And Ingredion Partner To Manufacture And Market Sugar Reduction And Fermentation-based Food Ingredients

Amyris, Inc. (AMRS) closed at $14.56 in the latest trading session, marking a -1.42% move from the prior day.

Amyris, Inc. (AMRS) Dips More Than Broader Markets: What You Should Know

Amyris, Inc. (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amyris, Inc. (AMRS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

EMERYVILLE, Calif., April 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the third webinar in its virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology.

Amyris Hosts Successful Final Session Of Its Three-Part Virtual Mini-Series

EMERYVILLE, Calif., April 21, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS) a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the first quarter ended March 31, 2021 on Thursday, May 6, 2021 prior to the opening of the financial markets.

Amyris To Host First Quarter 2021 Financial Results Conference Call On May 6

EMERYVILLE, Calif., April 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has executed a binding term sheet for the acquisition of Gen Z-focused beauty brand, EcoFabulous Cosmetics (EcoFabulous).

Amyris To Acquire EcoFabulous Clean Beauty Brand Focused On Fast-Growing Gen Z Consumer Segment

EMERYVILLE, Calif., April 14, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has agreed to acquire Beauty Labs International Ltd.

Amyris To Acquire Beauty Labs Combining Clean Beauty Leadership With Digital Innovation

Amyris, Inc. (NASDAQ:AMRS) is a synthetic biotech and renewable chemical company.

Unpacking This Sustainable Biotech Stock Breakout

EMERYVILLE, Calif., April 9, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the pricing of an underwritten public offering of an aggregate of 19,047,619 shares of its common stock at a public offering price of $15.75 per share, which consists of a secondary offering of 11,390,797 shares to be sold, in the aggregate, by DSM International B.V.

Amyris Announces Pricing of a $300.0 Million Public Offering (Secondary and Primary) of Common Stock

EMERYVILLE, Calif., April 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the commencement of a proposed underwritten public offering of shares of its common stock.

Amyris Announces Proposed Public Offering (Secondary And Primary) Of Common Stock

If you check the summary page for Amyris Inc. (NASDAQ:AMRS) at GuruFocus, you'll find a lot of weak metrics. That includes ratings of 1 out of 10 for both financial strength and profitability.

Amyris: A Mid-Cap That May Become a Significant Disruptor

EMERYVILLE, Calif., April 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will participate in a fireside chat at Cowen's 2nd Annual Consumer Platforms for the Next Generation Summit on Tuesday, April 6 th at 9:30 am ET.

Amyris to Present at Cowen's 2nd Annual Consumer Platforms for the Next Generation Summit on April 6, 2021

EMERYVILLE, Calif., April 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will host the third webinar in its virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology.

Amyris To Host Third Webinar In Its Virtual Investor Mini-Series

Just as Intel advanced the Digital Revolution and Tesla the EV Revolution, Amyris can drive the Synthetic Biology Revolution to replace high margin segments of the $5.7 Trillion chemical industry.

News for Amyris Stock (AMRS)